Official online community of SupplyExpo

  Current | By Company | NEW Products | Free Newsletters
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

BioGaia Signs Agreement For Germany
2006-10-24 - BioGaia




BioGaia has signed an agreement with HSO Pharma, Austria giving the company exclusive rights to market BioGaia´s probiotic tablets and drops in Germany.    
 
BioGaia and HSO entered into a distribution contract for the Austrian market at the end of 2005. HSO is selling BioGaia´s products since July through pharmacies in Austria. This cooperation has now been extended to comprise also Germany.

The products will be sold through pharmacies in Germany; the tablets under the BioGaia brand and the drops under the HSO Pharma brand. The launch will take place during next year.

"We have experienced a successful cooperation with HSO in the Austrian market. We look forward to extend it further in the German market. The launch of BioGaia´s products in Germany is important for BioGaia. The German market is big and the potential for our products is significant" says Peter Rothschild, President BioGaia AB.

HSO Pharma is experienced in probiotics and is focusing on marketing of innovative products for gut, vaginal and oral health.

BioGaia´s probiotic drops are today sold through pharmacies in 10 countries whilst the tablets are sold in 12 countries. New Contracts have been signed for a further 17 countries for the drops and 15 countries for the tablets. Launch for these markets is expected to take place during 2006 and 2007.

Latest press releases from BioGaia:
2006-08-16 BioGaia signs agreement with Ewopharma
2006-08-30 BioGaia´s probiotic oil drops halve hospital stay
2006-08-24 BioGaia AB Interim report 1 January – 30 June 2006

For additional information contact:
Peter Rothschild, president, telephone: +46 (0)8 - 555 293 00
Jan Annwall, executive vice president, telephone: +46 (0)8 – 555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the small cap list of the Stockholm Stock Exchange.

 




Sponsored Links: Featured Links:
 

NPIcenter Address and Phone Number
Contact Us | Privacy Policy | Terms of Use | Advertise
New Hope Natural Media

 

SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon